{"title":"骨质疏松的生物制剂:我们在哪里?","authors":"Gheita Tamer A, Fathi Hanan M","doi":"10.23937/2572-3243.1510059","DOIUrl":null,"url":null,"abstract":"Citation: Gheita TA, Fathi HM (2018) Biologics for Osteoporosis: Where Do We Stand?. J Musculoskelet Disord Treat 4:059. doi.org/10.23937/2572-3243.1510059 Accepted: November 10, 2018: Published: November 12, 2018 Copyright: © 2018 Gheita TA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Biologics for Osteoporosis: Where Do We Stand?","PeriodicalId":16374,"journal":{"name":"Journal of musculoskeletal disorders and treatment","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Biologics for Osteoporosis: Where Do We Stand?\",\"authors\":\"Gheita Tamer A, Fathi Hanan M\",\"doi\":\"10.23937/2572-3243.1510059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Citation: Gheita TA, Fathi HM (2018) Biologics for Osteoporosis: Where Do We Stand?. J Musculoskelet Disord Treat 4:059. doi.org/10.23937/2572-3243.1510059 Accepted: November 10, 2018: Published: November 12, 2018 Copyright: © 2018 Gheita TA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Biologics for Osteoporosis: Where Do We Stand?\",\"PeriodicalId\":16374,\"journal\":{\"name\":\"Journal of musculoskeletal disorders and treatment\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of musculoskeletal disorders and treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2572-3243.1510059\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of musculoskeletal disorders and treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2572-3243.1510059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Biologics for Osteoporosis: Where Do We Stand?
Citation: Gheita TA, Fathi HM (2018) Biologics for Osteoporosis: Where Do We Stand?. J Musculoskelet Disord Treat 4:059. doi.org/10.23937/2572-3243.1510059 Accepted: November 10, 2018: Published: November 12, 2018 Copyright: © 2018 Gheita TA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Biologics for Osteoporosis: Where Do We Stand?